FHIR IG analytics

Resources that use this resource

No resources found

Resources that this resource uses

Narrative

No narrative content found in resource

Source1

{
  "resourceType": "ValueSet",
  "id": "2.16.840.1.113762.1.4.1234.75",
  "meta": {
    "versionId": "6",
    "lastUpdated": "2023-12-21T17:43:03.000-05:00",
    "profile": [
      "http://hl7.org/fhir/StructureDefinition/shareablevalueset",
      "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/computable-valueset-cqfm",
      "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"
    ]
  },
  "extension": [
    {
      "url": "http://hl7.org/fhir/StructureDefinition/valueset-author",
      "valueContactDetail": {
        "name": "BEST System Author"
      }
    },
    {
      "url": "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate",
      "valueDate": "2024-04-04"
    },
    {
      "url": "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate",
      "valueDate": "2022-01-06"
    }
  ],
  "url": "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1234.75",
  "identifier": [
    {
      "system": "urn:ietf:rfc:3986",
      "value": "urn:oid:2.16.840.1.113762.1.4.1234.75"
    }
  ],
  "version": "20220106",
  "name": "COVID19VaccineICD10PCSCodesForExposureIdentification",
  "title": "COVID19 vaccine ICD10PCS codes for exposure identification",
  "status": "active",
  "experimental": false,
  "date": "2022-01-06T01:02:20-05:00",
  "publisher": "BEST System Steward",
  "jurisdiction": [
    {
      "coding": [
        {
          "system": "urn:iso:std:iso:3166",
          "code": "US"
        }
      ]
    }
  ],
  "purpose": "(Clinical Focus: COVID-19 vaccine ICD10PCS codes for identification of potential biologics-related adverse events.),(Data Element Scope: This value set may use a model element in the QDM category of Procedure/Intervention, Immunization, Medication, or Substance.),(Inclusion Criteria: COVID-19 vaccine ICD10PCS codes.),(Exclusion Criteria: None)",
  "compose": {
    "include": [
      {
        "system": "http://www.cms.gov/Medicare/Coding/ICD10",
        "concept": [
          {
            "code": "XW013S6",
            "display": "Introduction of COVID-19 Vaccine Dose 1 into Subcutaneous Tissue, Percutaneous Approach, New Technology Group 6"
          },
          {
            "code": "XW013T6",
            "display": "Introduction of COVID-19 Vaccine Dose 2 into Subcutaneous Tissue, Percutaneous Approach, New Technology Group 6"
          },
          {
            "code": "XW013U6",
            "display": "Introduction of COVID-19 Vaccine into Subcutaneous Tissue, Percutaneous Approach, New Technology Group 6"
          },
          {
            "code": "XW023S6",
            "display": "Introduction of COVID-19 Vaccine Dose 1 into Muscle, Percutaneous Approach, New Technology Group 6"
          },
          {
            "code": "XW023T6",
            "display": "Introduction of COVID-19 Vaccine Dose 2 into Muscle, Percutaneous Approach, New Technology Group 6"
          },
          {
            "code": "XW023U6",
            "display": "Introduction of COVID-19 Vaccine into Muscle, Percutaneous Approach, New Technology Group 6"
          }
        ]
      }
    ]
  },
  "expansion": {
    "identifier": "urn:uuid:33f17690-c72b-4014-bc35-dc775e2d4e30",
    "timestamp": "2025-05-23T20:15:25-04:00",
    "total": 6,
    "contains": [
      {
        "system": "http://www.cms.gov/Medicare/Coding/ICD10",
        "version": "2025",
        "code": "XW013S6",
        "display": "Introduction of COVID-19 Vaccine Dose 1 into Subcutaneous Tissue, Percutaneous Approach, New Technology Group 6"
      },
      {
        "system": "http://www.cms.gov/Medicare/Coding/ICD10",
        "version": "2025",
        "code": "XW013T6",
        "display": "Introduction of COVID-19 Vaccine Dose 2 into Subcutaneous Tissue, Percutaneous Approach, New Technology Group 6"
      },
      {
        "system": "http://www.cms.gov/Medicare/Coding/ICD10",
        "version": "2025",
        "code": "XW013U6",
        "display": "Introduction of COVID-19 Vaccine into Subcutaneous Tissue, Percutaneous Approach, New Technology Group 6"
      },
      {
        "system": "http://www.cms.gov/Medicare/Coding/ICD10",
        "version": "2025",
        "code": "XW023S6",
        "display": "Introduction of COVID-19 Vaccine Dose 1 into Muscle, Percutaneous Approach, New Technology Group 6"
      },
      {
        "system": "http://www.cms.gov/Medicare/Coding/ICD10",
        "version": "2025",
        "code": "XW023T6",
        "display": "Introduction of COVID-19 Vaccine Dose 2 into Muscle, Percutaneous Approach, New Technology Group 6"
      },
      {
        "system": "http://www.cms.gov/Medicare/Coding/ICD10",
        "version": "2025",
        "code": "XW023U6",
        "display": "Introduction of COVID-19 Vaccine into Muscle, Percutaneous Approach, New Technology Group 6"
      }
    ]
  }
}